Literature DB >> 33629893

Silencing of long noncoding RNA H19 alleviates pulmonary injury, inflammation, and fibrosis of acute respiratory distress syndrome through regulating the microRNA-423-5p/FOXA1 axis.

Xianyu Mu1, Hongrong Wang1, Haiyong Li1.   

Abstract

PURPOSE: This study aimed to explore the regulatory effects and mechanisms of long noncoding RNA H19 (H19) on pulmonary injury, inflammation, and fibrosis of acute respiratory distress syndrome (ARDS).
MATERIALS AND METHODS: A rat model of ARDS was established by intratracheal instillation of 2 mg/kg lipopolysaccharide (LPS). qRT-PCR was performed to detect the expression of H19, miR-423-5p, tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, monocyte chemoattractant protein (MCP)-1, and vascular endothelial growth factor (VEGF). Histology score was assessed by hematoxylin-eosin (HE) staining. Enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of proinflammatory cytokines and the content of VEGF in bronchoalveolar lavage fluid (BALF). The lung fibrosis was evaluated using western blot and Masson's trichrome staining. Dual-luciferase reporter gene assay was used for confirming the relationship between miR-423-5p and H19/FOXA1 in alveolar macrophage cells (MH-S) and alveolar epithelial cells (MLE-12). The regulatory effects of H19/miR-423-5p/FOXA1 axis on the inflammation and fibrosis were further analyzed in LPS-induced MH-S cells.
RESULTS: The expression of H19 and FOXA1 was significantly up-regulated, while the expression of miR-423-5p was down-regulated in LPS-induced ARDS rats. Silencing of H19 decreased the mRNA expression of TNF-α, IL-1β, IL-6, MCP-1, and VEGF, the contents of TNF-α, IL-1β, IL-6, and VEGF in BALF, and histology score in LPS-induced ARDS rats. H19 knockdown also reduced the fibrosis scores and the protein expression of vimentin and α-SMA, and elevated the protein expression of E-cadherin in LPS-induced ARDS rats. Furthermore, silencing of miR-423-5p and overexpression of FOXA1 reversed the inhibitory effects of si-H19 on the inflammation and fibrosis of LPS-induced MH-S cells.
CONCLUSIONS: Silencing of H19 relieved the pulmonary injury, inflammation and fibrosis of LPS-induced ARDS in rats. Silencing of H19 also alleviated the inflammation and fibrosis of LPS-induced MH-S cells through regulating the miR-423-5p/FOXA1 axis.

Entities:  

Keywords:  H19; LPS-induced ARDS; miR-423-5p; pulmonary fibrosis; pulmonary inflammation

Mesh:

Substances:

Year:  2021        PMID: 33629893     DOI: 10.1080/01902148.2021.1887967

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  8 in total

Review 1.  Long non-coding RNA (lncRNA): A potential therapeutic target in acute lung injury.

Authors:  Almaz Zaki; M Shadab Ali; Vijay Hadda; Syed Mansoor Ali; Anita Chopra; Tasneem Fatma
Journal:  Genes Dis       Date:  2021-08-14

2.  Heterogeneous microenvironment analysis to explore the potential regulatory role of endothelial-mesenchymal transition in idiopathic pulmonary fibrosis.

Authors:  Yinning Xu; Xiaoping Hu; Yiwen Zhang; Zongfu Pan; Zhiyong Sun; Zhongjie Huang; Shuilian Zheng; Hansheng Pan; Xiaozhou Zou; Ping Huang
Journal:  Ann Transl Med       Date:  2022-04

3.  Circular RNA HIPK3 aggravates sepsis-induced acute kidney injury via modulating the microRNA-338/forkhead box A1 axis.

Authors:  Hulin Lu; Yan Chen; Xiaoyi Wang; Yong Yang; Min Ding; Fengping Qiu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

4.  Expression and 7-day time course of circulating microRNAs in septic patients treated with nephrotoxic antibiotic agents.

Authors:  Nadezda Petejova; Arnost Martinek; Josef Zadrazil; Viktor Klementa; Lenka Pribylova; Radim Bris; Marcela Kanova; Radka Sigutova; Ivana Kacirova; Zdenek Svagera; Eva Bace; David Stejskal
Journal:  BMC Nephrol       Date:  2022-03-19       Impact factor: 2.388

5.  Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.

Authors:  Ching-Tse Ting; Bor-Sen Chen
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

6.  Severe COVID-19 Pneumonia and Genetic Susceptibility: A Case Report and Literature Review.

Authors:  Badr A Alsayed; Rashid Mir
Journal:  Cureus       Date:  2022-03-30

7.  Long Non-Coding RNAs in Cardiac and Pulmonary Fibroblasts and Fibrosis.

Authors:  Mirolyuba Ilieva; Shizuka Uchida
Journal:  Noncoding RNA       Date:  2022-07-15

8.  Transcriptomic and Epigenetic Profiling of Fibroblasts in Idiopathic Pulmonary Fibrosis.

Authors:  Ankit Hanmandlu; Lisha Zhu; Tinne C J Mertens; Scott Collum; Weizhen Bi; Feng Xiong; Ruoyu Wang; Rajarajan T Amirthalingam; Dewei Ren; Leng Han; Soma S S K Jyothula; Wenbo Li; W Jim Zheng; Harry Karmouty-Quintana
Journal:  Am J Respir Cell Mol Biol       Date:  2022-01       Impact factor: 7.748

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.